Preview

Osteoporosis and Bone Diseases

Advanced search

Hypercalcemia with the development of chronic kidney disease, nephrolithiasis after intramuscular injection of oil solutions

https://doi.org/10.14341/osteo13141

Abstract

One of the rare causes of PTH-independent hypercalcemia can be anabolic oil solution, injected intramuscularly by bodybuilders, along with anabolic hormones, in order to make the muscles more prominent. Here is the clinical report of a 43-year-old patient who used Synthol oil solution at the age of 25–30 years is presented. He had long-term undiagnosed hypercalcemia that manifested with nephrolithiasis and progressing chronic kidney disease (CKD). For the first time hypercalcemia was diagnosed at the age of 37, but left omitted. In 2023 (43 years) the laboratory findings sowed extremely high calcium level (4.26 mmol/l) with decreased PTH and CKD C4. Malignancy hypercalcemia was excluded. With this case, the rare cause of hypercalcemia has been proven – intramuscular oil injection resulting in nephrolithiasis, nephrocalcinosis and CKD. Treatment with glucocorticoids has demonstrated positive effect, similar to the ones of granulomatous diseases and hypercalcemia. The mechanisms of PTH-independent hypercalcemia development and differential diagnosis are currently being discussed. The presented clinical case of a rare cause of hypercalcemia may be useful for doctors of various specialties: endocrinologists, therapists, urologists, dermatologists, etc.

About the Authors

G. E. Runova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Gusel E. Runova - MD, PhD.

Moscow


Competing Interests:

None



E. D. Pesheva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Ekaterina D. Pesheva - assistant of the department.

Moscow


Competing Interests:

None



A. A. Vastistova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Anastasiya A. Vastistova - clinical resident.

1/1 Pogodinskaya street, 119435, Moscow


Competing Interests:

None



L. Ya. Rozhinskaya
Endocrinology Research Centre
Russian Federation

Ludmila Ya. Rozhinskaya - MD, PhD, professor.

Moscow


Competing Interests:

None



I. V. Poluboyarinova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Irina V. Poluboyarinova - MD, PhD.

Moscow


Competing Interests:

None



M. P. Vasilevskaya
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Mariya P. Vasilyeva - MD, PhD.

Moscow


Competing Interests:

None



O. Yu. Gurova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Olesya Yu. Gurova - MD, PhD.

Moscow


Competing Interests:

None



V. V. Fadeev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Valentin V. Fadeev - MD, ScD, professor, corresponding member of the RAS.

Moscow


Competing Interests:

None



References

1. Marcocci C. and Cetani F. Primary hyperparathyroidism. The New England Journal of Medicine. Vol. 365, no. 25, pp. 2389-2397, 201; doi: https://doi.org/10.1056/NEJMcp1106636

2. Fisken RA, Heath DA, Bold AM. Hypercalcaemia — a hospital survey. Q J Med. 1980;49:405-418

3. Thomas P. Jacobs, Martin Kaufman, Glenville Jones, et al. A Lifetime of Hypercalcemia and Hypercalciuria. Finally Explained Clinical Endocrinology and Metabolism. March 2014, 99(3):708-712 doi: https://doi.org/10.1210/jc.2013-3802

4. Рожинская Л.Я., Пушкарева А.С., Мамедова Е.О. и соавт. Паратгормон-независимая гиперкальциемия и гиперкальциурия у пациента с нефролитиазом и нефрокальцинозом, обусловленные нарушением метаболизма витамина D вследствие дефекта гена CYP24A1 // Остеопороз и остеопатии. 2021; 24(1):26-33. doi: https://doi.org/10.14341/osteo12920

5. Anne Sophie KoldkjarS0lling et al. Non-parathyroid hypercalcemia associated with paraffin oil injection in 12 younger male bodybuilders: a case series. Eur J Endocrinol. 2018 Jun;178(6):K29-K37; doi: https://doi.org/10.1530/EJE-18-0051

6. Andrea Sisti et al. Oil injection for cosmetic enhancement of the upper extremities: a case report and review of literature. J Acta Biomed. 2020; 91(3):e2020082; doi: https://doi.org/10.23750/abm.v91i3.8533

7. Banke IJ, Prodinger PM, Waldt S, et al. Irreversible muscle damage in bodybuilding due to long-term intramuscular oil injection. International journal of sports medicine. 2012;33:829-34. doi: https://doi.org/10.1055/s-0032-1311582

8. Hamm C, Azad S. Delayed oleoma formation with injection of oil-suspended testosterone: A case report and review of pathogenesis. SAGE Open Medical Case Reports. 2022;10; doi: https://doi.org/10.1177/2050313X221086318

9. Di Benedetto G, Pierangeli M, Scalise A. Bertani A. Paraffin oil injection in the body: an obsolete and destructive procedure. Ann Plast Surg. 2002;49:391-6.; doi: https://doi.org/10.1097/00000637-200210000-00010

10. Laitano FF, Gazzale A, Siqueira EJ, et al. Complicates de autoinjejao de agentes quimicos para aumento muscular. Rev Bras Cir Plast. 2016:31; doi: https://doi.org/10.5935/2177-1235.2016RBCP0022

11. Moraitis AG, Hewison M, Collins M, et al. Hypercalcemia associated with mineral oil-induced sclerosing paraffinomas. Endocr Pract. 2013;19(2):e50-6; doi: https://doi.org/10.4158/EP12092.CR

12. Munchow H. Paraffin-oil damage to tissue as in the example of calcified paraffinomas in mammae. Radiol Diagn. 1966;7(6):743-7

13. Georgieva J, Assaf C, Steinhoff M, et al. Bodybuilder oleoma. The British Journal Of Dermatology. 2003;149:1289-90; doi: https://doi.org/10.1111/j.1365-2133.2003.05742.x

14. Iversen L, Lemcke A, Bitsch M, Karlsmark T. Compression bandage as treatment for ulcers induced by intramuscular self-injection of paraffin oil. Acta Dermato-venereologica. 2009;89:196-7; doi: https://doi.org/10.2340/00015555-0583

15. Koopman M, Richter C, Parren RJ, Janssen M. Bodybuilding, sesame oil and vasculitis. Rheumatology. 2005;44:1135; doi: https://doi.org/10.1093/rheumatology/keh712

16. Gyldenlove M, Rorvig S, Skov L, Hansen D. Severe hypercalcaemia, nephrocalcinosis, and multiple paraffinomas caused by paraffin oil injections in a young bodybuilder. Lancet. 2014;383(9934):2098; doi: https://doi.org/10.1016/S0140-6736(14)60806-0

17. Hall M, Grogan S, Gough B. Bodybuilders' accounts of synthol use: The construction of lay expertise online. Journal of health psychology. 2016;21:1939-48; doi: https://doi.org/10.1177/1359105314568579

18. Henriksen TF, Lovenwald JB, Matzen SH. Paraffin oil injection in bodybuilders calls for preventive action. Ugeskrift For Laeger. 2010;172:219-20

19. Ebbe Eldrup, 1 Simone Theilade et al. Hypercalcemia After Cosmetic Oil Injections: Unraveling Etiology, Pathogenesis, and Severity. Journal of Boneand Mineral Research. 2021

20. Jonathan Zagzag, MD, MPH1 et al. Hypercalcemia and Cancer: Differential Diagnosisand Treatment. CACancer J Clin. 2018 Sep;68(5):377-386; doi: https://doi.org/10.3322/caac.21489

21. Trivalle C, Profit P, Bonnet B, et al. Liver lipogranulomas with longterm fever caused by paraffin oil. Gastroenterol Clin Biol. 1991;15 (6-7):551-3

22. Schafer CN, Hvolris J, Karlsmark T, Plambech M. Muscle enhancement using intramuscular injections of oil in bodybuilding: review on epidemiology, complications, clinical evaluation and treatment. European Surgery: ACA Acta Chirurgica Austriaca. 2012;44:109-15; doi: https://doi.org/10.1007/s10353-011-0033-z


Supplementary files

1. Рисунок 1. Места инъекций масляных растворов.
Subject
Type Данные
View (178KB)    
Indexing metadata ▾

Review

For citations:


Runova G.E., Pesheva E.D., Vastistova A.A., Rozhinskaya L.Ya., Poluboyarinova I.V., Vasilevskaya M.P., Gurova O.Yu., Fadeev V.V. Hypercalcemia with the development of chronic kidney disease, nephrolithiasis after intramuscular injection of oil solutions. Osteoporosis and Bone Diseases. 2023;26(3):33-39. (In Russ.) https://doi.org/10.14341/osteo13141

Views: 1429


ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)